{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:58:55Z","timestamp":1695542335493},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.11.092","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T09:44:46Z","timestamp":1292492686000},"page":"1228-1234","source":"Crossref","is-referenced-by-count":13,"title":["Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: A phase III open-label single-arm study"],"prefix":"10.1016","volume":"29","author":[{"given":"M.","family":"Loebermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Anders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Brestrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fritzsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Klammt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bor\u0161o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Frimmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Riebold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.C.","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"June (25)","key":"10.1016\/j.vaccine.2010.11.092_bib0005","first-page":"2605","article-title":"Emergence of a novel swine-origin influenza A (H1N1) virus in humans","volume":"360","author":"Dawood","year":"2009","journal-title":"N Engl J Med"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2010.11.092_bib0010","first-page":"400","article-title":"Swine influenza A (H1N1) infection in two children\u2014Southern California, March\u2013April 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"July (5937)","key":"10.1016\/j.vaccine.2010.11.092_bib0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2010.11.092_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MCP.0b013e3283375727","article-title":"Features of the new pandemic influenza A\/H1N1\/2009 virus: virology, epidemiology, clinical and public health aspects","volume":"16","author":"Tang","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2010.11.092_bib0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1086\/655226","article-title":"A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trial","volume":"202","author":"Wu","year":"2010","journal-title":"J Infect Dis"},{"issue":"31","key":"10.1016\/j.vaccine.2010.11.092_bib0030","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1016\/j.vaccine.2010.05.031","article-title":"The 2009 A (H1N1) influenza virus pandemic: a review","volume":"28","author":"Girard","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.092_bib0035","series-title":"Recommended viruses for influenza vaccines for use in the 2010\u20132011 northern hemisphere influenza season","author":"WHO","year":"2010"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.11.092_bib0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-2478(99)00171-6","article-title":"Preservative-free influenza vaccine","volume":"71","author":"Banzhoff","year":"2000","journal-title":"Immunol Lett"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2010.11.092_bib0045","first-page":"338","article-title":"Safety of an influenza-split-vaccine in children","volume":"213","author":"Schmitt-Grohe","year":"2001","journal-title":"Klin Padiatr"},{"issue":"4","key":"10.1016\/j.vaccine.2010.11.092_bib0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/vim.2004.17.609","article-title":"Antibody response to influenza vaccination in healthy adults","volume":"17","author":"Brydak","year":"2004","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2010.11.092_bib0055","series-title":"Note for guidance on harmonisation of requirements for influenza vaccines. Committee for medicinal products for human use","year":"1997"},{"key":"10.1016\/j.vaccine.2010.11.092_bib0060","series-title":"Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines","year":"2007"},{"key":"10.1016\/j.vaccine.2010.11.092_bib0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2334-10-71","article-title":"Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons","volume":"10","author":"Jackson","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.11.092_bib0070","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/JCM.29.3.498-505.1991","article-title":"In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory","volume":"29","author":"Powers","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2010.11.092_bib0075","doi-asserted-by":"crossref","first-page":"c2649","DOI":"10.1136\/bmj.c2649","article-title":"Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study","volume":"340","author":"Waddington","year":"2010","journal-title":"BMJ"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.11.092_bib0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/erv.10.23","article-title":"Safety and immunogenicity of influenza A H1N1 vaccines","volume":"9","author":"Lu","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2010.11.092_bib0085","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMc0909988","article-title":"Responses to 2009 H1N1 vaccine in children 3 to 17 years of age","volume":"362","author":"Arguedas","year":"2010","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.11.092_bib0090","first-page":"37","article-title":"Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial","volume":"303","author":"Nolan","year":"2009","journal-title":"JAMA"},{"issue":"December (25)","key":"10.1016\/j.vaccine.2010.11.092_bib0095","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa0907650","article-title":"Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine","volume":"361","author":"Clark","year":"2009","journal-title":"N Engl J Med"},{"issue":"December (25)","key":"10.1016\/j.vaccine.2010.11.092_bib0100","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1056\/NEJMoa0908535","article-title":"A novel influenza A (H1N1) vaccine in various age groups","volume":"361","author":"Zhu","year":"2009","journal-title":"N Engl J Med"},{"issue":"January (9708)","key":"10.1016\/j.vaccine.2010.11.092_bib0105","first-page":"49","article-title":"Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009\u201310 influenza season: a multicentre, randomised controlled trial","volume":"375","author":"Vajo","year":"2009","journal-title":"Lancet"},{"issue":"August","key":"10.1016\/j.vaccine.2010.11.092_bib0110","first-page":"279","article-title":"Recommendations of the standing vaccination commission (STIKO)","volume":"30","year":"2010","journal-title":"Epidemiol Bull"},{"key":"10.1016\/j.vaccine.2010.11.092_bib0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-10-134","article-title":"Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study","volume":"10","author":"Van Damme","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2010.11.092_bib0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-4933-5-2","article-title":"Safety and immunogenicity of an MF59-adjuvanted subunit influenza vaccine in elderly Chinese subjects","volume":"5","author":"Li","year":"2008","journal-title":"Immun Ageing"},{"issue":"30","key":"10.1016\/j.vaccine.2010.11.092_bib0125","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.30.19624-en","article-title":"Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August\u2013October 2009","volume":"15","author":"Tsai","year":"2010","journal-title":"Euro Surveill"},{"issue":"November (20)","key":"10.1016\/j.vaccine.2010.11.092_bib0130","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2010.11.092_bib0135","first-page":"229","article-title":"Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"issue":"7","key":"10.1016\/j.vaccine.2010.11.092_bib0140","doi-asserted-by":"crossref","first-page":"e11601","DOI":"10.1371\/journal.pone.0011601","article-title":"Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA","volume":"5","author":"Zimmer","year":"2010","journal-title":"PLoS ONE"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2010.11.092_bib0145","first-page":"39","article-title":"High titers of hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran","volume":"7","author":"Moghadami","year":"2010","journal-title":"Iran J Immunol"},{"issue":"March (9720)","key":"10.1016\/j.vaccine.2010.11.092_bib0150","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(09)62126-7","article-title":"Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study","volume":"375","author":"Miller","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.11.092_bib0155","series-title":"H1N1 in post-pandemic period","author":"Chan","year":"2010"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1001738X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1001738X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T17:36:55Z","timestamp":1636997815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1001738X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X1001738X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.092","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}